Cibc Private Wealth Group, LLC Veracyte, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 986 shares of VCYT stock, worth $26,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
986
Previous 936
5.34%
Holding current value
$26,602
Previous $37,000
21.62%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VCYT
# of Institutions
306Shares Held
79.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$223 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$210 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$141 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$106 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$104 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.93B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...